Abstract
The aims of this study were to screen peptide inhibitors specific for isocitrate lyase (ICL) using a phage peptide library and computer molecular docking and to explore the relevant mechanisms. Using ICL as a target, the phage peptide library was screened to obtain peptides with specific binding affinity. Based on the three-dimensional crystal structure of ICL(pdb:1F8I), the obtained polypeptides were docked to the 1F8I using the computer-simulated molecular docking technique. The successfully docked polypeptides were synthesized using the Fmoc solid-phase synthesis method, and the ICL inhibition rate of these peptides was measured. Finally, the possible mechanism underlying the inhibition was explored by Binding Site Analysis. A total of 29 heptapeptides were obtained through screening the phage peptide library. We found that 12 out of the 29 peptides were successfully docked to the 1F8I, and all 12 peptides could obviously inhibit the ICL activity, of which three heptapeptides showed an inhibiting (extent of inhibition over 50 %), IC50 value of 126 μM. Structural analysis revealed that the ICL tetramer has a large cavity in the center, and the polypeptides bind to ICL at amino acid residue 119’s GLN of the ICL monomer. We successfully obtained peptide inhibitors specific for ICL, and analyzed the mechanism underlying the interaction between the peptides and ICL. Our study provides scientific evidence for the development of antituberculosis peptide drugs targeting ICL.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ali HI, Nagamatsu T, Akaho E (2011) Structure-based drug design and AutoDock study of potential protein tyrosine kinase inhibitors. Bioinformation 5:368–374
Bikadi Z, Hazai E (2009) Application of the PM6 semi-empirical method to modeling proteins enhances docking accuracy of AutoDock. J Cheminform 1:15
Cardoso LP, Stefani MM (2009) High level of multidrug resistance mutations in HIV type 1 pol gene and resistance-associated mutations to enfuvirtide (T-20) among antiretroviral-experienced patients from central Brazil. AIDS Res Hum Retrovir 25:943–950
Edwards JS, Kumbhar A, Roberts A, Hemmert AC, Edwards CC et al (2011) Immobilization of active human carboxylesterase 1 in biomimetic silica nanoparticles. Biotechnol Prog 27:863–869
Goodsell DS (2009) Computational docking of biomolecular complexes with AutoDock. Cold Spring Harb Protoc 2009: pdb prot5200
Hancock R, Bertrand HC, Tsujita T, Naz S, El-Bakry A et al (2012) Peptide inhibitors of the Keap1-Nrf2 protein–protein interaction. Free Radic Biol Med 52:444–451
Hogle WP (2004) Abarelix (plenaxis). Clin J Oncol Nurs 8:663–665
Krepstakies M, Lucifora J, Nagel CH, Zeisel MB, Holstermann B et al (2012) A new class of synthetic peptide inhibitors block attachment and entry of human pathogenic viruses. J Infect Dis 205(11):1654–1664
Lee HS, Yoon KM, Han YR, Lee KJ, Chung SC et al (2009) 5-Hydroxyindole-type alkaloids, as Candida albicans isocitrate lyase inhibitors, from the tropical sponge Hyrtios sp. Bioorg Med Chem Lett 19:1051–1053
Lee YJ, Han YR, Park W, Nam SH, Oh KB et al (2010) Synthetic analogs of indole-containing natural products as inhibitors of sortase A and isocitrate lyase. Bioorg Med Chem Lett 20:6882–6885
Lorenz MC, Fink GR (2001) The glyoxylate cycle is required for fungal virulence. Nature 412:83–86
Ogiso T, Iwaki M, Tanino T, Nishioka S, Higashi K et al (1997) In vitro skin penetration and degradation of enkephalin, elcatonin and insulin. Biol Pharm Bull 20:54–60
Oh KB, Jeon HB, Han YR, Lee YJ, Park J et al (2010) Bromophenols as Candida albicans isocitrate lyase inhibitors. Bioorg Med Chem Lett 20:6644–6648
Patra SM, Bastug T, Kuyucak S (2007) Binding of organic cations to gramicidin A channel studied with AutoDock and molecular dynamics simulations. J Phys Chem B 111:11303–11311
Pierce BG, Hourai Y, Weng Z (2011) Accelerating protein docking in ZDOCK using an advanced 3D convolution library. PLoS ONE 6:e24657
Schmidt AG, Yang PL, Harrison SC (2010) Peptide inhibitors of dengue-virus entry target a late-stage fusion intermediate. PLoS Pathog 6:e1000851
Sharma V, Sharma S, Hoener zu Bentrup K, McKinney JD, Russell DG et al (2000) Structure of isocitrate lyase, a persistence factor of Mycobacterium tuberculosis. Nat Struct Biol 7:663–668
Shi W, Ma H, Duan Y, Aubart K, Fang Y et al (2011) Design, synthesis and antibacterial activity of 3-methylenepyrrolidine formyl hydroxyamino derivatives as novel peptide deformylase inhibitors. Bioorg Med Chem Lett 21:1060–1063
Sriram D, Yogeeswari P, Methuku S, Vyas DR, Senthilkumar P et al (2011) Synthesis of various 3-nitropropionamides as Mycobacterium tuberculosis isocitrate lyase inhibitor. Bioorg Med Chem Lett 21:5149–5154
Terwilliger TC, Park MS, Waldo GS, Berendzen J, Hung LW et al (2003) The TB structural genomics consortium: a resource for Mycobacterium tuberculosis biology. Tuberculosis (Edinb) 83:223–249
Wu P, Weisell J, Pakkala M, Perakyla M, Zhu L et al (2010) Identification of novel peptide inhibitors for human trypsins. Biol Chem 391:283–293
Yu-he Y, Xue N (2011) Screening peptide inhibitors using phage peptide library with the isocitrate lyse in Mycobacterium tuberculosis. Chem Res Chin Univ 27(4):635–640
Acknowledgments
This study was supported by the technology development funds of the Education Department of jilin Province (No. 2008110).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00044-013-0845-4